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Catalytic enantioselective synthesis of α-chiral azaheteroaryl 
ethylamines by asymmetric protonation 
Chao Xu,[a] Calum W. Muir,[b] Andrew G. Leach,[c] Alan R. Kennedy,[b] and Allan J. B. Watson[a]* 
Abstract: The direct enantioselective synthesis of chiral 
azaheteroarylethylamines from vinyl aza-heterocycles and anilines is 
reported. A chiral phosphoric acid (CPA) catalyst promotes 
dearomatizing aza-Michael addition giving a prochiral exocyclic aryl 
enamine, which undergoes asymmetric protonation upon 
rearomatization. The reaction accommodates a broad range of 
azaheterocycle, nucleophile, and substituent on the prochiral centre, 
generating the products in high enantioselectivity. DFT studies 
support a facile nucleophilic addition based on catalyst-induced 
LUMO lowering, with site-selective, rate-limiting, intramolecular 
asymmetric proton transfer from the ion-paired prochiral intermediate. 
(Hetero)arylethylamines are prolific in natural and synthetic 
bioactive molecules and pharmaceuticals for numerous disease 
indications.[1] Natural substances such as adrenaline, 
amphetamine, histamine, and thyroxine are critically important to 
human health and have been used as templates for the 
development of treatments for a broad range of disease states. 
Access to de novo chiral scaffolds has proven valuable for the 
development of new ligands for discrete targets (e.g., Scheme 
1a).  
On heterocyclic scaffolds, numerous approaches have been 
made to allow formation of the α- and β-stereocentre.[2,3] 
However, methods to directly access the α-stereocentre on the 
β-amino template are rare. Asymmetric hydrogenation is 
perhaps the most effective but requires prior synthesis of an 
enamine precursor,[4] while hydroamination is generally more 
effective intramolecularly.[5] 
Here, we present a method for the asymmetric synthesis of 
this important compound class based on a chiral phosphoric 
acid (CPA)-catalyzed dearomatizing aza-Michael/rearomatizing 
asymmetric protonation of 1,1-vinyl azaheterocycles (Scheme 
1b). This provides direct modular access to chiral 
azaheteroarylethyl amines from simple precursors via the 
formation of a new C-N bond, and with concomitant formation of 
the α-stereocentre in high enantioselectivity.[6] DFT studies are 
presented to rationalize the observed reactivity as well as the 
origin of the asymmetric induction. 
 
Scheme 1. (a) Examples of (hetero)arylethylamines. (b) This work: 
(Hetero)arylethylamines via conjugate addition/asymmetric protonation. 
Vinyl heterocycles are competent conjugate acceptors[2] and 
aza-Michael addition to vinyl heterocycles has been shown to 
proceed in refluxing AcOH.[7] We reasoned that a CPA catalyst 
might allow LUMO-lowering protonation of a 1,1-disubstituted 2-
vinyl azaheterocycle to allow a more facile reaction (Scheme 
1b).[8,9] Subsequent asymmetric protonation upon 
rearomatization would set the α-stereocentre.[10-12] While 
seemingly straightforward, the system must be pKa balanced. 
Since both reactants and the product would contain Lewis basic 
sites, mismatched pKa may inhibit catalyst turnover. 
Enantiofacial control during the key asymmetric protonation 
event would be catalyst-driven and contingent on high 
diastereocontrol in the formation of the prochiral enamine 
intermediate, enforced by H-bonding between the catalyst and 
both reactants during the dearomatizing nucleophilic addition.  
Using an amine nucleophile, the dearomatizing conjugate 
addition would likely be reversible. As such, we hypothesized 
that the dearomatization would be facilitated by the retention of a 
benzenoid ring. Accordingly, initial reaction development was 
based on the 1,1-disubstituted 2-vinyl quinoline 1 and aniline 2 
as our benchmark system. An initial round of screening of CPAs 
identified the widely successful TRIP catalyst 3 as the most 
promising (Table 1, see ESI for full details of catalyst 
investigation).[10,11,13] Stronger CPAs were ineffective, which we 
attribute to ineffective catalyst turnover due to the weaker 
conjugate base. No conversion was recorded in the absence of 
catalyst (entry 1); however, 73% conversion to 4a with 91:9 e.r. 
was recorded using 20 mol% 3 at 0 °C (entry 2) with THF found 
to be the most suitable solvent (entries 2-6). Optimization of 
catalyst and nucleophile loading and temperature (entries 7-11) 
delivered an effective system that provided 75% conversion to 
4a with 97:3 e.r. using 20 mol% 3 at –20 °C (entry 9). Lower 
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catalyst loadings were not favorable over same reaction time 
period (entries 10 and 11).†  
 
Table 1. Reaction development.[a] 
 
Entry 3 (mol%) Solvent Temp. (°C) % conv. (e.r.)[b] 
1 ----- THF 0 0 (---) 
2 20 THF 0 73 (91:9) 
3 20 Et2O 0 75 (78:22) 
4 20 CH2Cl2 0 4 (---) 
5 20 PhMe 0 84 (60:40) 
6 20 Hexane 0 62 (78:22) 
7 20 THF –10 76 (94:6) 
8 20 THF –20 57 (96:4) 
9[c] 20 THF –20 75 (97:3) 
10[c] 10 THF –20 26 (95:5) 
11[c] 5 THF –20 14 (92:8) 
[a] 1 (1 equiv), 2 (2 equiv), solvent (0.5 M). [b] Determined by HPLC analysis. 
See ESI. [c] Using 3 equiv 2. 
 
The generality of the method is shown in Scheme 2. A broad 
range of aniline was tolerated, with small variations of efficiency 
and selectivity as a function of the electronic parameters of the 
anilines, in line with DFT observations of key π-stacking 
interactions (vide infra). Alkyl amines were not successful due to 
catalyst inhibition through salt formation (not shown, see ESI). 
The substituent on the prochiral center could be varied to a 
range of aryl units without major impact on the enantioselectivity 
(Scheme 2b). Alkyl groups were not tolerated well, giving 
moderate enantioselectivity (not shown; see ESI), which we 
believe stems from the removal of key π-stacking interactions 
between the components (vide infra).  
 
Scheme 2. Substrate scope. Isolated yields. Enantiomeric ratio determined by 
HPLC analysis. See ESI. aReaction temp. = 40 °C. bUsing 100 mol% 3 at –40 
°C. 
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Lastly, the azaheterocycle could be varied to a number of 
derivatives, adhering to the regiochemical requirements of the 
vinyl unit (Scheme 2c). Less reactive heterocyclic templates 
required increased temperature for reactivity (4aj, 4ak), which 
compromised enantioinduction. Introducing a substituent to the 
3-positon of the quinoline (4ag) template led to major negative 
effects on conversion and selectivity, due to allylic strain 
consistent with the mechanistic rationale (vide infra), while some 
stark selectivity variance was observed between similar 
heterocyclic templates based on electronic differences (e.g., 4ah, 
4ai). 
An example of potential utility in medicinal chemistry is 
shown from 4am. Hydrogenation of naphthyridine 4am delivers 
piperidinopyridine scaffold 5, an arginine mimetic[14] and, 
specifically, a key pharmacophore within RGD αv-integrin drug 
discovery.[15] 
The mechanism of the process was rationalized by DFT 
calculations (Scheme 3).[16] Protonation of the substrate 1 by 
catalyst 6 leads to LUMO-lowered pyridinium ion pair 7, which 
also benefits from a CH-O hydrogen bond between the C8-H 
and another of the phosphate oxygens (H-O = 2.33 Å). H-
bonding interactions between the catalyst, heterocycle, and 
incoming nucleophile (2) orients 2 to pick up additional π-
stacking interactions with the aryl substituent on the prochiral 
centre (phenyl, in the model shown), enforcing high levels of 
diastereocontrol in the formation of the prochiral enamine in the 
subsequent conjugate addition. Based on this preorganization, 
the addition is a surprisingly low energy process proceeding via 
TS1 to deliver the key prochiral E-enamine intermediate ion pair 
8. This intermediate cannot be observed (NMR) based on the 
pre-RLS equilibrium. The C-N bond in this intermediate is weak 
(C-N = 1.57 Å) and the species relies on stabilization via a 
strong hydrogen bond between the anilinium ion and the 
phosphate oxygen (N-H…O=P, N-H = 1.12 Å and H-O = 1.42 Å).  
The anilinium also benefits from a π-cation interaction with the 
catalyst. The retention of the quinolinium-phosphate H-bond, the 
anilinium-phosphate H-bond, and the CH-O H-bond imposes 
tight geometric limits on the bound substrate. Alternative modes 
of aniline addition are significantly disfavored (not shown, see 
ESI for details). 
Ion pair 8 undergoes the rate-limiting rearomatizing 
asymmetric protonation. Using the R-catalyst (shown), this gives 
preferential protonation of the Re-face of the enamine to deliver 
the S-product, proceeding via 4- membered transition state TS2, 
transferring the proton from the anilinic ammonium rather than 
heterocyclic NH to deliver the quinolinium product ion pair 9. 
This event is favored by ca. 0.7 kcal mol-1 over the alternative 
protonation of the Si-face. Interestingly, H-bonding of the chiral 
anion to the heterocyclic NH and an anilinium NH controls this 
protonation event, but the anion is not involved as a proton 
shuttle. The three anchoring polar interactions are retained in 
the transition state. A key observation from these calculations 
was the product ion pair complex 9 is higher in free energy than 
substrate activation complex 7, which suggests no product 
inhibition of the catalysis. An intramolecular H-bonding 
interaction between the newly installed aniline NH and the 
heterocyclic nitrogen, as observed in solid state (e.g., 4g, 
Scheme 2a), may explain tempered Lewis basicity in the product, 
facilitating catalyst turnover.  
  
 
Scheme 3. DFT calculated energy profile for preferred pathway. Free energies in kcal/mol (computed at 298 K with corrections to 1 
M) were computed at the M06-2X/6-31+G*(+IEFPCM)//M06-2X/3-21G level of theory.[17-21] 
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Preliminary kinetic studies support a 1st order dependency 
with respect to all three components (vinyl heterocycle, aniline 
nucleophile, and catalyst), consistent with the DFT analysis (see 
ESI). Finally, 31P NMR and HRMS analysis supported a 
preferential substrate/catalyst pairing (i.e., 1•3) rather than 
product/catalyst (i.e., 4a•3), consistent with the turnover 
hypothesis (see ESI).  
In summary, we have developed a CPA-catalyzed 
enantioselective synthesis of α-chiral azaheteroaryl ethylamines 
via dearomatizing aza-Michael/rearomatizing asymmetric 
protonation. DFT and kinetic studies have given insight into the 
mechanism of the reaction, which will guide future applications 
of this approach towards the design and synthesis of 
functionalized heterocyclic scaffolds. 
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